Skip to main content
OpenTrials

Clinical trial condition

Advanced Malignancies

Explore clinical trials studying Advanced Malignancies. Study availability and eligibility vary by location and protocol.

59 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Advanced Malignancies trial results

Completed

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
  • Columbia University Medical Center New York, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details
Completed

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

NCT03763149

Conditions
Advanced Malignancies
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • Thomas Jefferson Univerity Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • START (South Texas Accelerated Research Therapeutics, LLC) San Antonio, Texas, United States
View Trial Details
Completed

ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants

NCT02737501

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +17 more
Locations
  • USOR - Arizona Oncology Associates - Sedona Sedona, Arizona, United States
  • Kaiser Permanente Bellflower Medical Offices Bellflower, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers - Boulder Boulder, Colorado, United States
View all 91 locations
View Trial Details
Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

NCT02697591

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +36 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

NCT00420524

Conditions
Advanced Malignancies, Neoplasms, Tumors
Locations
  • University of California San Diego/Moores Cancer Center La Jolla, California, United States
  • Cancer Research and Treatment Center Albuquerque, New Mexico, United States
  • Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

NCT02383212

Conditions
Advanced Cancer, Advanced Malignancies
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Western Regional Medical Center Goodyear, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
View all 47 locations
View Trial Details

Related conditions